Basal cell carcinoma CT scan: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Basal cell carcinoma}} | {{Basal cell carcinoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{M.N}} | ||
==Overview== | ==Overview== | ||
[[CT scan]] is mainly used for the [[Staging (pathology)|staging]] of the basal cell carcinoma rather than [[Diagnose|diagnosing]] the [[tumor]]. [[CT scan]] images usually shows hypoattenuating or isoattenuating [[lesions]] when compared to adjacent [[musculature]] | |||
==CT scan== | ==CT scan== | ||
| Line 24: | Line 15: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
[[Category:Surgery]] | |||
[[Category:Radiology]] | |||
Latest revision as of 15:18, 6 March 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma CT scan On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma CT scan |
|
Risk calculators and risk factors for Basal cell carcinoma CT scan |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
CT scan is mainly used for the staging of the basal cell carcinoma rather than diagnosing the tumor. CT scan images usually shows hypoattenuating or isoattenuating lesions when compared to adjacent musculature
CT scan
- It is mainly used for the staging of the basal cell carcinoma rather than diagnosing the tumor[1]
- CT scan images usually shows hypoattenuating or isoattenuating lesions when compared to adjacent musculature
References
- ↑ Baheti AD, Tirumani SH, Giardino A, Rosenthal MH, Tirumani H, Krajewski K, Ramaiya NH (February 2015). "Basal cell carcinoma: a comprehensive review for the radiologist". AJR Am J Roentgenol. 204 (2): W132–40. doi:10.2214/AJR.14.13160. PMID 25615773.